Literature DB >> 21777513

Evaluating the progenitor cells of ovarian cancer: analysis of current animal models.

Shelby M King1, Joanna E Burdette.   

Abstract

Serous ovarian cancer is one of the most lethal gynecological malignancies. Progress on effective diagnostics and therapeutics for this disease are hampered by ambiguity as to the cellular origins of this histotype of ovarian cancer, as well as limited suitable animal models to analyze early stages of disease. In this report, we will review current animal models with respect to the two proposed progenitor cells for serous ovarian cancer, the ovarian surface epithelium and the fallopian tube epithelium.

Entities:  

Mesh:

Year:  2011        PMID: 21777513      PMCID: PMC3677720          DOI: 10.5483/BMBRep.2011.44.7.435

Source DB:  PubMed          Journal:  BMB Rep        ISSN: 1976-6696            Impact factor:   4.778


  89 in total

Review 1.  Ovarian surface epithelium: biology, endocrinology, and pathology.

Authors:  N Auersperg; A S Wong; K C Choi; S K Kang; P C Leung
Journal:  Endocr Rev       Date:  2001-04       Impact factor: 19.871

2.  Role of K-ras and Pten in the development of mouse models of endometriosis and endometrioid ovarian cancer.

Authors:  Daniela M Dinulescu; Tan A Ince; Bradley J Quade; Sarah A Shafer; Denise Crowley; Tyler Jacks
Journal:  Nat Med       Date:  2004-12-26       Impact factor: 53.440

3.  Selected Background Findings and Interpretation of Common Lesions in the Female Reproductive System in Macaques.

Authors:  J Mark Cline; Charles E Wood; Justin D Vidal; Ross P Tarara; Eberhard Buse; Gerhard F Weinbauer; Eveline P C T de Rijk; Eric van Esch
Journal:  Toxicol Pathol       Date:  2008-12       Impact factor: 1.902

4.  Conditional inactivation of Brca1 in the mouse ovarian surface epithelium results in an increase in preneoplastic changes.

Authors:  Katherine V Clark-Knowles; Kenneth Garson; Jos Jonkers; Barbara C Vanderhyden
Journal:  Exp Cell Res       Date:  2006-10-03       Impact factor: 3.905

Review 5.  Spontaneous ovarian tumors in twelve baboons: a review of ovarian neoplasms in non-human primates.

Authors:  Charleen M Moore; Gene B Hubbard; M Michelle Leland; Betty G Dunn; Robert G Best
Journal:  J Med Primatol       Date:  2003-02       Impact factor: 0.667

6.  Serous carcinogenesis in the fallopian tube: a descriptive classification.

Authors:  Elke Jarboe; Ann Folkins; Marisa R Nucci; David Kindelberger; Ronny Drapkin; Alexander Miron; Yonghee Lee; Christopher P Crum
Journal:  Int J Gynecol Pathol       Date:  2008-01       Impact factor: 2.762

7.  Expression of activated PIK3CA in ovarian surface epithelium results in hyperplasia but not tumor formation.

Authors:  Shun Liang; Nuo Yang; Yue Pan; Shan Deng; Xiaojuan Lin; Xiaojun Yang; Dionyssios Katsaros; Katherine F Roby; Thomas C Hamilton; Denise C Connolly; George Coukos; Lin Zhang
Journal:  PLoS One       Date:  2009-01-27       Impact factor: 3.240

8.  Evidence for a latent precursor (p53 signature) that may precede serous endometrial intraepithelial carcinoma.

Authors:  Elke A Jarboe; Ellen S Pizer; Alexander Miron; Nick Monte; George L Mutter; Christopher P Crum
Journal:  Mod Pathol       Date:  2009-01-16       Impact factor: 7.842

9.  Ovarian tumors of the hen.

Authors:  T N Fredrickson
Journal:  Environ Health Perspect       Date:  1987-08       Impact factor: 9.031

10.  Ovarian carcinomas with genetic and epigenetic BRCA1 loss have distinct molecular abnormalities.

Authors:  Joshua Z Press; Alessandro De Luca; Niki Boyd; Sean Young; Armelle Troussard; Yolanda Ridge; Pardeep Kaurah; Steve E Kalloger; Katherine A Blood; Margaret Smith; Paul T Spellman; Yuker Wang; Dianne M Miller; Doug Horsman; Malek Faham; C Blake Gilks; Joe Gray; David G Huntsman
Journal:  BMC Cancer       Date:  2008-01-22       Impact factor: 4.430

View more
  15 in total

Review 1.  Recreating the female reproductive tract in vitro using iPSC technology in a linked microfluidics environment.

Authors:  Monica M Laronda; Joanna E Burdette; J Kim; Teresa K Woodruff
Journal:  Stem Cell Res Ther       Date:  2013-12-20       Impact factor: 6.832

Review 2.  Minireview: animal models and mechanisms of ovarian cancer development.

Authors:  Lisa K Mullany; JoAnne S Richards
Journal:  Endocrinology       Date:  2012-03-06       Impact factor: 4.736

Review 3.  Ovarian cancer stem cells: elusive targets for chemotherapy.

Authors:  Achuta Kumar Guddati
Journal:  Med Oncol       Date:  2012-05-26       Impact factor: 3.064

4.  Capturing Small Molecule Communication Between Tissues and Cells Using Imaging Mass Spectrometry.

Authors:  Katherine E Zink; Matthew Dean; Joanna E Burdette; Laura M Sanchez
Journal:  J Vis Exp       Date:  2019-04-03       Impact factor: 1.355

5.  Progesterone Receptor Serves the Ovary as a Trigger of Ovulation and a Terminator of Inflammation.

Authors:  Chan Jin Park; Po-Ching Lin; Sherry Zhou; Radwa Barakat; Shah Tauseef Bashir; Jeong Moon Choi; Joseph A Cacioppo; Oliver R Oakley; Diane M Duffy; John P Lydon; CheMyong J Ko
Journal:  Cell Rep       Date:  2020-04-14       Impact factor: 9.423

6.  Advantages of the avian model for human ovarian cancer.

Authors:  Ana DE Melo Bernardo; Sólveig Thorsteinsdóttir; Christine L Mummery
Journal:  Mol Clin Oncol       Date:  2015-08-11

7.  Technical challenges and limitations of current mouse models of ovarian cancer.

Authors:  Kenneth Garson; Lisa F Gamwell; Elizabeth Mg Pitre; Barbara C Vanderhyden
Journal:  J Ovarian Res       Date:  2012-11-29       Impact factor: 4.234

8.  Gonadotropins activate oncogenic pathways to enhance proliferation in normal mouse ovarian surface epithelium.

Authors:  Tyvette S Hilliard; Dimple A Modi; Joanna E Burdette
Journal:  Int J Mol Sci       Date:  2013-02-28       Impact factor: 5.923

9.  Spontaneous Transformation of Murine Oviductal Epithelial Cells: A Model System to Investigate the Onset of Fallopian-Derived Tumors.

Authors:  Michael P Endsley; Georgette Moyle-Heyrman; Subbulakshmi Karthikeyan; Daniel D Lantvit; David A Davis; Jian-Jun Wei; Joanna E Burdette
Journal:  Front Oncol       Date:  2015-07-17       Impact factor: 6.244

10.  Modeling High-Grade Serous Carcinoma: How Converging Insights into Pathogenesis and Genetics are Driving Better Experimental Platforms.

Authors:  Paul Michael Jones; Ronny Drapkin
Journal:  Front Oncol       Date:  2013-08-26       Impact factor: 6.244

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.